These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 31726452

  • 1. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 4. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Mar 31; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 5. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K, Dressler D, Woldag H, Koßmehl P, Koch M, Maisonobe P, Reichel G.
    Nervenarzt; 2019 Apr 31; 90(4):361-370. PubMed ID: 30324541
    [Abstract] [Full Text] [Related]

  • 6. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC.
    Toxins (Basel); 2020 Dec 04; 12(12):. PubMed ID: 33291807
    [Abstract] [Full Text] [Related]

  • 7. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 04; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.
    J Neurol Sci; 2014 Feb 15; 337(1-2):86-90. PubMed ID: 24361062
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 10. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE.
    Disabil Rehabil; 2016 Sep 24; 38(19):1927-33. PubMed ID: 26714558
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH.
    Pan Afr Med J; 2020 Sep 24; 35():55. PubMed ID: 32523646
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A, Visvanathan R, Cameron I, Koblar SA, Howell S, Wilson D.
    BMC Neurol; 2019 May 11; 19(1):96. PubMed ID: 31078139
    [Abstract] [Full Text] [Related]

  • 13. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct 11; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 14. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K.
    BMJ Open; 2016 Jun 17; 6(6):e011157. PubMed ID: 27315835
    [Abstract] [Full Text] [Related]

  • 15. Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions.
    Moore EJ, Olver J, Bryant AL, McKenzie DP, Williams G.
    Brain Inj; 2018 Jun 17; 32(7):948-956. PubMed ID: 29718712
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F.
    J Rehabil Med; 2014 Sep 17; 46(8):730-7. PubMed ID: 25073939
    [Abstract] [Full Text] [Related]

  • 17. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.
    Disabil Rehabil; 2013 Apr 17; 35(7):596-605. PubMed ID: 22928803
    [Abstract] [Full Text] [Related]

  • 18. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Apr 17; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 17; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 20. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
    Khat'kova SE, Khasanova DR, Korenko LA, Antipova LN, Shperling LP, Popov DV, Pokhabov DV, Poznyakova EV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Jun 17; 115(7):89-97. PubMed ID: 26356520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.